Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 60/100

Failure Rate

5.6%

8 terminated/withdrawn out of 142 trials

Success Rate

78.4%

-8.1% vs industry average

Late-Stage Pipeline

6%

9 trials in Phase 3/4

Results Transparency

7%

2 of 29 completed trials have results

Key Signals

21 recruiting2 with results7 withdrawn

Enrollment Performance

Analytics

N/A
48(57.1%)
Phase 2
22(26.2%)
Phase 4
5(6.0%)
Phase 3
4(4.8%)
Phase 1
3(3.6%)
Early Phase 1
2(2.4%)
84Total
N/A(48)
Phase 2(22)
Phase 4(5)
Phase 3(4)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (142)

Showing 20 of 142 trials
NCT07453875Phase 1Not Yet Recruiting

LDRT Sequential NIPS Immunochemotherapy for Peritoneal Metastasis of Gastric and Colorectal Cancer

Role: lead

NCT05515796Phase 2Completed

Multi-omics Sequencing in Neoadjuvant Immunotherapy of Gastrointestinal Tumors

Role: lead

NCT03653156Recruiting

China Cognition and Aging Study

Role: collaborator

NCT03657732Recruiting

The Chinese Familial Alzheimer's Network

Role: collaborator

NCT07468630Phase 2Recruiting

Tolecizumab Plus Chemoimmunotherapy for pMMR/MSS Locally Advanced Colon Adenocarcinoma

Role: lead

NCT07467590Phase 2Not Yet Recruiting

Combination of High and Low-Dose Radiotherapy With Immune Therapy and TKI in Advanced Colorectal Cancer: A Phase II Study

Role: lead

NCT07459179Not Yet Recruiting

Clinical Study on the Application of PET Probes Targeting DDR2 in the Diagnosis of Interstitial Lung Disease With Cognitive Impairment

Role: lead

NCT07459205Not Yet Recruiting

Clinical Application of 68Ga-1A12 PET in Fibrosis-related Diseases

Role: lead

NCT07459192Not Yet Recruiting

Clinical Study of 68Ga-DOTA-BLP PET Imaging in Noninvasive Diagnosis of Malignant Tumors

Role: lead

NCT07448441Not Yet Recruiting

Clinical Study of Trap-(FAPI)3 PET Imaging in the Diagnosis of Pulmonary Nodules

Role: lead

NCT07440212Not Yet Recruiting

Clinical Study on Noninvasive Evaluation of Ivonescimab Antibody Distribution and Expression in Esophageal Cancer Patients by 89Zr-AK112 PET Imaging

Role: lead

NCT07405372Recruiting

Construction and Application of an IDH Mutation-Targeted PET/MRI Imaging Framework for Precision Diagnosis of Gliomas

Role: lead

NCT04184921Phase 2Completed

Combination of Osimertinib and Aspirin to Treat EGFR Mutation NSCLC Patients

Role: lead

NCT07376876Phase 2Not Yet Recruiting

Indocyanine Green-guided Omental Shield Anastomosis for Cervical Esophagogastric Anastomosis in Minimally Invasive McKeown Esophagectomy

Role: lead

NCT07354698Phase 4Not Yet Recruiting

Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery

Role: lead

NCT07237126Not ApplicableNot Yet Recruiting

Single-port Robotic Radical Gastrectomy for Gastric Cancer

Role: lead

NCT03736707Not ApplicableRecruiting

High-Frequency Oscillation Ventilation Versus Conventional Mechanical Ventilation in Very Preterm Infants With Perinatal Acute Respiratory Distress Syndrome: Multicenters Randomized Controlled, Superiority Trial

Role: lead

NCT06192212Completed

PPIO-005 The Relationship Between Different Nutritional Pathways and Tumor Outcomes After Minimally Invasive Esophagectomy

Role: lead

NCT06333665Completed

PPIO-007 Correlation Analysis of Type II Diabetes Mellitus on Short-term and Long-term Outcomes of Patients With Esophageal Squamous Cell Cancer Undergoing Minimally Invasive Esophagectomy

Role: lead

NCT07195786Not Yet Recruiting

Expansion-floating Craniotomy for the Treatment of Malignant Cerebral Edema Caused by Acute Ischemic Stroke

Role: lead